EXHIBIT 99
LIFEPOINT
HOSPITALS, INC.
CONTACT: MICHAEL J. CULOTTA
SENIOR VICE PRESIDENT AND
CHIEF FINANCIAL OFFICER
(615) 372-8512
LIFEPOINT HOSPITALS REPORTS FOURTH QUARTER
AND YEAR-END RESULTS
BRENTWOOD, TENNESSEE (February 18, 2003) - LifePoint Hospitals, Inc. (NASDAQ:
LPNT) today announced results for the fourth quarter and year ended December 31,
2002.
For the quarter ended December 31, 2002, net revenues were $201.9
million, up 22.9% from $164.3 million a year ago. Income before extraordinary
item for the quarter totaled $17.8 million, or $0.45 per diluted share, versus
$10.3 million, or $0.27 per diluted share in the prior year period, representing
increases of 72.5% and 66.7%, respectively. Including extraordinary items, net
income for the quarter totaled $17.6 million, or $0.44 per diluted share, versus
$10.3 million, or $0.27 per diluted share in the prior-year period, representing
increases of 70.1% and 63.0%, respectively. Earnings before interest, income
taxes, depreciation, amortization, ESOP expense, minority interest, and
extraordinary loss (EBITDA) increased 29.7% to $45.9 million for the quarter
from $35.3 million in the same period last year.
For the year ended December 31, 2002, net revenues were $743.6 million,
up 20.0% from $619.4 million a year ago. Income before extraordinary item for
the year totaled $60.6 million, or $1.56 per diluted share, versus $34.9
million, or $0.94 per diluted share in the prior year, representing increases of
73.6% and 66.0%, respectively. Including extraordinary items, net income for the
year totaled $41.5 million, or $1.10 per diluted share, versus $33.3 million, or
$0.90 per diluted share in the prior-year period, representing increases of
24.6% and 22.2%, respectively. Earnings before interest, income taxes,
depreciation, amortization, ESOP expense, minority interest, gain on previously
impaired assets and extraordinary loss (EBITDA) increased 27.6% to $167.7
million for the year from $131.4 million in the same period last year.
During the fourth quarter of 2002, the Company completed the
acquisitions of the following five hospitals: 100-bed Russellville Hospital,
located in Russellville, Alabama; 132-bed Logan General Hospital and its
affiliated entities, which include Guyan Valley Hospital, a 19-bed critical
access hospital, all located in Logan, West Virginia; 99-bed Burdick-West
Medical Center in Haleyville, Alabama; and 71-bed Northwest Medical Center in
Winfield, Alabama. In addition, the Company acquired the remaining 30% interest
in Dodge City Healthcare Group, L.P., the joint venture that owns and operates
110-bed Western Plains Regional Hospital in Dodge City, Kansas. These
acquisitions increase the number of facilities operated by LifePoint Hospitals
to 28.
Kenneth C. Donahey, chairman and chief executive officer of LifePoint
Hospitals, said, "By most measures, 2002 has been an exceptional year for
LifePoint Hospitals. Our financial results have been outstanding, driven by
strong operating performance and intense fiscal discipline. In addition, in our
non-urban communities, we have invested approximately $60.7 million in 2002,
helping to expand and improve services. And, finally, we have added five new
facilities to our family of hospitals throughout the nation, bringing the total
to 28.
-MORE-
LPNT Announces Year-End Results
Page 2
February 18, 2003
"LifePoint Hospitals' success in 2002 demonstrates that serving the
needs of communities and serving the interests of shareholders represents a
positive alignment of incentives. This confluence of interests has enabled our
company to grow increasingly stronger. For the future, we will build upon these
strengths. Through disciplined growth, continuous improvements and prudent
investments, we believe we are better positioned than ever to continue adding
value for our shareholders and for our 27 communities throughout the United
States."
A listen-only simulcast and replay of LifePoint Hospitals' fourth
quarter and year-end conference call will be available on-line at
www.lifepointhospitals.com and www.companyboardroom.com on February 19, 2003,
beginning at 10:00 a.m. Eastern Time.
LifePoint Hospitals, Inc. operates 28 hospitals in non-urban areas. In
most cases, the LifePoint facility is the only hospital in its community.
LifePoint's non-urban operating strategy offers continued operational
improvement by focusing on its five core values: delivering high quality patient
care, supporting physicians, creating excellent workplaces for its employees,
providing community value, and ensuring fiscal responsibility. Headquartered in
Brentwood, Tennessee, LifePoint Hospitals is affiliated with approximately 9,000
employees.
******
This release includes forward-looking statements based on current
management expectations. Numerous factors exist which may cause results to
differ from these expectations. Many of the factors that will determine the
Company's future results are beyond the ability of the Company to control or
predict with accuracy. These statements are subject to various risks and
uncertainties relating to the Company, including, without limitation, (i)
changes in reimbursement to healthcare providers by government and commercial
third party payors that may reduce payments, as well as cost-containment efforts
of insurers and other payors; (ii) its ability to attract and retain qualified
management and personnel, including physicians, nurses and clinical support
personnel; (iii) the geographic concentration of the Company's operations; (iv)
risks associated with the Company's acquisition and capital improvements
strategies; (v) the ability of the Company to successfully integrate newly
acquired facilities; (vi) managing healthcare risks resulting from the delivery
of patient care and the lack of state and federal tort reform; (vii) the
regulated nature of the healthcare industry; (viii) the highly competitive
nature of the healthcare industry; (ix) the potential adverse impact of
government investigations and litigation involving the business practices of HCA
Inc. (to the extent relating to periods prior to the Company's formation) and of
other healthcare providers (to the extent such investigations and litigation may
affect the Company or its industry segment); (x) fluctuations in the market
value of the Company's common stock; (xi) the economic effects of local markets
and how employers will provide healthcare coverage to their employees; (xii)
changes in the Company's liquidity or indebtedness; (xiii) the availability,
cost and terms of insurance coverage for the Company and its physicians; (xiv)
changes in accounting policies and practices; (xv) changes in revenue mix and
the ability of the Company to enter into and renew managed care provider
arrangements on acceptable terms; (xvi) the ability to maintain and increase
patient volumes; (xvii) the possible enactment of Federal or state healthcare
reform; (xviii) the outcome of the Company's continuing efforts to monitor,
maintain and comply with appropriate laws, regulations, policies and procedures,
and the Company's corporate integrity agreement with the government; and (xix)
those risks and uncertainties described from time to time in the Company's
filings with the Securities and Exchange Commission. Therefore, the Company's
future results may differ materially from those described in this release. The
Company undertakes no obligation to update any forward-looking statements, or to
make any other forward-looking statements, whether as a result of new
information, future events or otherwise.
All references to "Company" and "LifePoint" as used throughout this
release refer to LifePoint Hospitals, Inc. and its affiliates.
-MORE-
LPNT Announces Year-End Results
Page 3
February 18, 2003
LIFEPOINT HOSPITALS, INC.
UNAUDITED CONSOLIDATED INCOME STATEMENTS
DOLLARS IN MILLIONS, EXCEPT PER SHARE AMOUNTS
FOR THE THREE MONTHS ENDED FOR THE YEARS ENDED
DECEMBER 31, DECEMBER 31,
--------------------------------------- ----------------------------------------
2002 2001 2002 2001
----------------- ----------------- ----------------- ------------------
AMOUNT RATIO AMOUNT RATIO AMOUNT RATIO AMOUNT RATIO
------ ----- ------ ----- ------ ----- ------ -----
Revenues(1) $201.9 100.0% $164.3 100.0% $743.6 100.0% $619.4 100.0%
Salaries and benefits 78.8 39.0% 64.2 39.1% 291.4 39.2% 243.2 39.3%
Supplies 24.8 12.3% 20.8 12.7% 92.2 12.4% 78.2 12.6%
Other operating expenses(1) 36.0 17.9% 32.3 19.6% 137.1 18.4% 120.8 19.5%
Provision for
doubtful accounts 16.4 8.1% 11.7 7.1% 55.2 7.4% 45.8 7.4%
Depreciation & amortization 9.9 4.9% 9.9 6.2% 37.9 5.1% 34.7 5.6%
Interest expense, net 3.4 1.7% 3.9 2.3% 13.3 1.8% 18.1 2.9%
Gain on previously
impaired assets -- --% -- --% -- --% (0.5) (0.1)%
ESOP expense 2.3 1.1% 2.4 1.4% 9.7 1.3% 10.4 1.7%
------ ----- ------ ----- ------ ----- ------ -----
171.6 85.0% 145.2 88.4% 636.8 85.6% 550.7 88.9%
------ ----- ------ ----- ------ ----- ------ -----
Income before minority
interest, income taxes
and extraordinary item 30.3 15.0% 19.1 11.6% 106.8 14.4% 68.7 11.1%
Minority interest -- --% 0.8 0.5% 2.2 0.3% 2.7 0.4%
------ ----- ------ ----- ------ ----- ------ -----
Income before income taxes
and extraordinary item 30.3 15.0% 18.3 11.1% 104.6 14.1% 66.0 10.7%
Provision for income taxes 12.5 6.2% 8.0 4.8% 44.0 5.9% 31.1 5.1%
------ ----- ------ ----- ------ ----- ------ -----
Income before
extraordinary item 17.8 8.8% 10.3 6.3% 60.6 8.2% 34.9 5.6%
Extraordinary loss on early
retirement of debt, net 0.2 0.1% -- --% 19.1 2.6% 1.6 0.2%
------ ----- ------ ----- ------ ----- ------ -----
Net income $ 17.6 8.7% $ 10.3 6.3% $ 41.5 5.6% $ 33.3 5.4%
====== ===== ====== ===== ====== ===== ====== =====
Shares used in diluted
EPS (000's) 44,010 38,353 41,867 37,148
Diluted earnings per share:
Income before
extraordinary item(2) $ 0.45 $ 0.27 $ 1.56 $ 0.94
Extraordinary loss on early
retirement of debt, net (0.01) -- (0.46) (0.04)
------ ------ ------ ------
Net income(3) $ 0.44 $ 0.27 $ 1.10 $ 0.90
====== ====== ====== ======
(1) The Company recorded prior year contractual adjustments that increased
revenues by $5.1 million for the fourth quarter of 2002 compared with
$0.1 million for the same period last year. For the year ended December
31, 2002, the Company recorded prior year contractual adjustments that
increased revenues by $13.0 million compared with $2.0 million for the
same period last year. Of the $13.0 million recorded for the year ended
December 31, 2002, $8.0 million is primarily related to cost reports
that were delayed by outpatient PPS and $5.0 million is related to the
favorable settlement of a Kentucky Medicaid rate appeal, which is
offset by related expenses of $0.9 million included in other operating
expenses. See "Supplemental Information" for further details elsewhere
in this release.
(2) See "Unaudited Earnings Per Share Calculation" for detail of
calculation elsewhere in this release.
(3) In April 2002, the Financial Accounting Standards Board (FASB) issued
FASB Statement No. 145, "Recission of FASB Statements No. 4, 44 and 64,
Amendment of FASB Statement No. 13, and Technical Corrections." The
recission of FASB Statement No. 4, "Reporting Gains and Losses from
Extinguishment of Debt," no longer allows companies to report gains or
losses from extinguishment of debt as an extraordinary item. Effective
January 1, 2003, the Company will adopt FASB Statement No. 145,
resulting in a $0.03 decrease in net income per diluted share from
$1.10 to $1.07 for the year ended December 31, 2002, but no change in
net income per diluted share for the three months ended December 31,
2002.
-MORE-
LPNT Announces Year-End Results
Page 4
February 18, 2003
LIFEPOINT HOSPITALS, INC.
UNAUDITED EARNINGS PER SHARE CALCULATION
DOLLARS IN MILLIONS, EXCEPT PER SHARE AMOUNTS
THREE MONTHS ENDED YEARS ENDED
DECEMBER 31, DECEMBER 31,
------------------ ------------------
2002 2001 2002 2001
------- ------- ------- -------
Numerator:
Numerator for basic earnings per share - income
before extraordinary item $ 17.8 $ 10.3 $ 60.6 $ 34.9
Effect of convertible notes 1.9 -- 4.6 --
------- ------- ------- -------
Numerator for diluted earnings per share - income
before extraordinary item $ 19.7 $ 10.3 $ 65.2 $ 34.9
======= ======= ======= =======
Denominator: (000s)
Denominator for basic earnings per share - weighted
average shares 37,736 37,190 37,536 35,714
Effect of dilutive securities:
Employee stock options 912 1,066 1,005 1,332
Other 83 97 86 102
Convertible notes 5,279 -- 3,240 --
------- ------- ------- -------
Denominator for diluted earnings per share - adjusted
weighted average shares 44,010 38,353 41,867 37,148
======= ======= ======= =======
Basic income before extraordinary item per share $ 0.47 $ 0.28 $ 1.62 $ 0.97
======= ======= ======= =======
Diluted income before extraordinary item per share $ 0.45 $ 0.27 $ 1.56 $ 0.94
======= ======= ======= =======
-MORE-
LPNT Announces Year-End Results
Page 5
February 18, 2003
LIFEPOINT HOSPITALS, INC.
CONSOLIDATED BALANCE SHEETS
DOLLARS IN MILLIONS
DECEMBER 31, DECEMBER 31,
2002 2001
------------ ------------
(UNAUDITED)
ASSETS
Current assets:
Cash and cash equivalents $ 23.0 $ 57.2
Accounts receivable, less allowances for doubtful accounts
of $109.1 and $59.0 at December 31, 2002 and 2001, respectively 85.0 56.7
Inventories 20.5 16.3
Deferred income taxes and other current assets 14.8 18.7
-------- --------
143.3 148.9
Property and equipment:
Land 11.3 10.7
Buildings and improvements 285.3 262.0
Equipment 295.5 263.4
Construction in progress 18.1 7.2
-------- --------
610.2 543.3
Accumulated depreciation (238.0) (204.9)
-------- --------
372.2 338.4
Deferred loan costs, net 8.6 7.1
Unallocated purchase price 136.1 12.6
Intangible assets, net 3.8 0.1
Other 0.3 0.1
Goodwill 69.2 47.1
-------- --------
$ 733.5 $ 554.3
======== ========
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable $ 28.5 $ 19.0
Accrued salaries 24.4 18.6
Other current liabilities 14.3 10.7
Estimated third-party payor settlements 8.2 17.9
-------- --------
75.4 66.2
Long-term debt 250.0 150.0
Deferred income taxes 24.9 21.0
Professional liability risks and other liabilities 25.6 16.9
Minority interest in equity of consolidated entity -- 5.2
Stockholders' equity:
Preferred stock -- --
Common stock 0.4 0.4
Capital in excess of par value 297.2 285.0
Unearned ESOP compensation (19.3) (22.5)
Notes receivable for shares sold to employees -- (5.7)
Retained earnings 79.3 37.8
-------- --------
357.6 295.0
-------- --------
$ 733.5 $ 554.3
======== ========
-MORE-
LPNT Announces Year-End Results
Page 6
February 18, 2003
LIFEPOINT HOSPITALS, INC.
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
DOLLARS IN MILLIONS
THREE MONTHS ENDED YEARS ENDED
DECEMBER 31, DECEMBER 31,
----------------------- -----------------------
2002 2001 2002 2001
-------- -------- -------- --------
Cash flows from operating activities:
Net income $ 17.6 $ 10.3 $ 41.5 $ 33.3
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization 9.9 9.9 37.9 34.7
ESOP expense 2.3 2.4 9.7 10.4
Minority interest in earnings of consolidated entity -- 0.8 2.2 2.7
Deferred income taxes 2.4 6.3 3.0 6.9
Reserve for professional liability risk, net 1.7 0.7 9.2 7.0
Extraordinary loss on early retirement of debt 0.6 -- 31.1 2.6
Gain on previously impaired assets -- -- -- (0.5)
Tax benefit from stock option exercises 0.4 -- 1.7 8.1
Increase (decrease) in cash from operating assets
and liabilities, net of effects from acquisitions:
Accounts receivable (2.1) 7.8 (16.9) (1.0)
Inventories and other current assets (1.8) (0.6) (3.2) (0.6)
Accounts payable and accrued expenses (9.9) (11.6) 1.7 2.8
Income taxes payable 7.0 (4.7) 6.9 (3.5)
Estimated third-party payor settlements (7.5) 0.9 (10.1) 9.6
Other 0.3 0.3 0.1 1.6
-------- -------- -------- --------
Net cash provided by operating activities 20.9 22.5 114.8 114.1
Cash flows from investing activities:
Purchases of property and equipment, net (18.5) (7.3) (60.7) (35.8)
Purchase of facilities, net of cash received (137.1) (30.7) (137.1) (36.5)
Purchase of minority interest (25.0) -- (25.0) --
Other 0.3 (0.3) (1.9) 4.0
-------- -------- -------- --------
Net cash used in investing activities (180.3) (38.3) (224.7) (68.3)
Cash flows from financing activities:
Proceeds from stock offering, net -- -- -- 100.4
Repayments of bank debt -- -- -- (139.3)
Repurchases of senior subordinated notes (3.4) -- (176.5) --
Proceeds from issuance of convertible notes, net -- -- 242.5 --
Proceeds from exercise of stock options 0.6 0.2 3.0 12.2
Proceeds from employee loans 0.5 -- 5.7 --
Other 0.9 (0.7) 1.0 (1.6)
-------- -------- -------- --------
Net cash (used in) provided by financing activities (1.4) (0.5) 75.7 (28.3)
Change in cash and cash equivalents (160.8) (16.3) (34.2) 17.5
Cash and cash equivalents at beginning of period 183.8 73.5 57.2 39.7
-------- -------- -------- --------
Cash and cash equivalents at end of period $ 23.0 $ 57.2 $ 23.0 $ 57.2
======== ======== ======== ========
Interest payments $ 7.3 $ 8.6 $ 16.3 $ 20.8
======== ======== ======== ========
Income taxes paid, net $ 2.8 $ 6.4 $ 21.0 $ 18.4
======== ======== ======== ========
-MORE-
LPNT Announces Year-End Results
Page 7
February 18, 2003
LIFEPOINT HOSPITALS, INC.
UNAUDITED SUPPLEMENTAL INFORMATION
DOLLARS IN MILLIONS
FOR THE THREE MONTHS ENDED FOR THE YEARS ENDED
DECEMBER 31, DECEMBER 31,
------------------------------------------ ------------------------------------------
2002 2001 2002 2001
------------------ ------------------ ------------------ ------------------
AMOUNT RATIO AMOUNT RATIO AMOUNT RATIO AMOUNT RATIO
------ ----- ------ ----- ------ ----- ------ -----
Revenues $201.9 102.5% $164.3 100.1% $743.6 101.7% $619.4 100.3%
Less: Prior year
contractual adjustments (5.1) (2.5)% (0.1) (0.1)% (13.0) (1.7)% (2.0) (0.3)%
------ ----- ------ ----- ------ ----- ------ -----
196.8 100.0% 164.2 100.0% 730.6 100.0% 617.4 100.0%
Salaries and benefits 78.8 40.0% 64.2 39.1% 291.4 39.9% 243.2 39.4%
Supplies 24.8 12.6% 20.8 12.7% 92.2 12.6% 78.2 12.7%
Other operating expenses 36.0 18.4% 32.3 19.6% 137.1 18.7% 120.8 19.5%
Less: Adjustment for
legal fees(1) -- 0.0% -- 0.0% (0.9) (0.1)% -- 0.0%
Provision for
doubtful accounts 16.4 8.3% 11.7 7.1% 55.2 7.6% 45.8 7.4%
------ ----- ------ ----- ------ ----- ------ -----
156.0 79.3% 129.0 78.5% 575.0 78.7% 488.0 79.0%
------ ----- ------ ----- ------ ----- ------ -----
EBITDA(2), excluding
prior year contractual
adjustments and
associated legal fees $ 40.8 20.7% $ 35.2 21.5% $155.6 21.3% $129.4 21.0%
====== ===== ====== ===== ====== ===== ====== =====
(1) Adjustment for legal fees are expenses incurred related to prior year
contractual adjustments.
(2) EBITDA is defined as income before depreciation and amortization,
interest expense, gain on previously impaired assets, ESOP expense,
minority interest in earnings of consolidated entity, extraordinary
items and income taxes. EBITDA is commonly used as an analytical
indicator within the healthcare industry and also serves as a measure
of leverage capacity and debt service ability. EBITDA should not be
considered as a measure of financial performance under accounting
principles generally accepted in the United States and the items
excluded from EBITDA are significant components in understanding and
assessing financial performance. EBITDA should not be considered in
isolation or as an alternative to net income, cash flows generated by
operating, investing or financing activities or other financial
statement data presented in the consolidated financial statements as an
indicator of financial performance or liquidity. Because EBITDA is not
a measurement determined in accordance with accounting principles
generally accepted in the United States and is susceptible to varying
calculations, EBITDA as presented may not be comparable to other
similarly titled measures of other companies.
-MORE-
LPNT Announces Year-End Results
Page 8
February 18, 2003
LIFEPOINT HOSPITALS, INC.
UNAUDITED STATISTICS
THREE MONTHS ENDED YEARS ENDED
DECEMBER 31, DECEMBER 31,
------------------------------------ --------------------------------------
2002 2001 % CHANGE 2002 2001 % CHANGE
------- ------- -------- -------- -------- --------
ACTUAL:
Number of hospitals at end of period 28 23 21.7% 28 23 21.7%
Licensed beds at end of period 2,617 2,197 19.1% 2,617 2,197 19.1%
Weighted average licensed beds 2,404 2,120 13.4% 2,248 2,011 11.8%
Average daily census 901 784 14.9% 865 783 10.5%
Average length of stay 4.0 4.0 0.0% 4.1 4.0 2.5%
Revenues ($ in millions) $ 201.9 $ 164.3 22.9% $ 743.6 $ 619.4 20.0%
Revenues per equivalent admission $ 5,131 $ 4,911 4.5% $ 4,986 $ 4,796 4.0%
Equivalent admissions(1) 39,353 33,461 17.6% 149,152 129,163 15.5%
Outpatient factor(1) 1.92 1.86 3.1% 1.91 1.82 5.0%
Outpatient surgeries 17,067 15,231 12.1% 65,545 57,423 14.1%
Inpatient surgeries 6,133 5,309 15.5% 23,030 20,042 14.9%
Emergency room visits 92,960 80,191 15.9% 355,891 313,110 13.7%
Admissions 20,531 17,988 14.1% 77,927 70,891 9.9%
Net outpatient revenues as a
percentage of net revenues 48.9% 48.2% N/A 49.8% 47.8% N/A
SAME-HOSPITAL(2):
Number of hospitals at end of period 21 21 0.0% 21 21 0.0%
Licensed beds at end of period 1,962 1,963 (0.1)% 1,962 1,963 (0.1)%
Weighted average licensed beds 1,962 1,963 (0.1)% 1,961 1,971 (0.5)%
Average daily census 765 747 2.4% 778 774 0.5%
Average length of stay 4.1 4.0 2.5% 4.1 4.0 2.5%
Revenues ($ in millions) $ 174.4 $ 154.8 12.7% $ 673.6 $ 609.8 10.5%
Revenues per equivalent admission $ 5,348 $ 4,966 7.7% $ 5,104 $ 4,806 6.2%
Equivalent admissions(1) 32,614 31,166 4.6% 131,976 126,868 4.0%
Outpatient factor(1) 1.89 1.83 3.6% 1.88 1.81 3.9%
Outpatient surgeries 15,127 14,308 5.7% 60,566 56,500 7.2%
Inpatient surgeries 5,284 5,041 4.8% 20,897 19,774 5.7%
Emergency room visits 76,297 73,938 3.2% 313,970 306,857 2.3%
Admissions 17,255 17,074 1.1% 70,051 69,977 0.1%
Net outpatient revenues as a
percentage of net revenues 48.5% 46.9% N/A 48.9% 47.5% N/A
(1) Equivalent admissions is used by management and investors as a general
measure of combined inpatient and outpatient volume. Equivalent
admissions is computed by multiplying admissions (inpatient volumes) by
the sum of gross inpatient revenue and gross outpatient revenue and
then dividing the resulting amount by gross inpatient revenue. The
equivalent admissions computation "equates" outpatient revenue to the
volume measure (admissions) used to measure inpatient volume resulting
in a general measure of combined inpatient and outpatient volume.
(2) Same-hospital information excludes the operations of hospitals that the
Company acquired during the years presented. The costs of corporate
overhead are included in same-hospital information.
-END -